Skip to main content

Table 1 Inclusion and exclusion criteria

From: Sevoflurane versus PRopofol combined with Remifentanil anesthesia Impact on postoperative Neurologic function in supratentorial Gliomas (SPRING): protocol for a randomized controlled trial

Inclusion Criteria

Patients aged between 18 to 65 years old with American Society of Anesthesiology (ASA) status I ~ II who are scheduled for elective craniotomy for the treatment of supratentorial gliomas must fulfill the following:

1

Frontal-Parietal-Temporal glioma diagnosed by preoperative MRI

2

Glasgow score of 15 without preoperative symptomatic elevated intracranial pressure

3

New and/or recurrent intracranial gliomas are allowed

Exclusion Criteria

1

Unable to comprehend and cooperate with the neurologic examination

2

Emergency craniotomy or changed to emergency from elective craniotomy

3

Insular lobe is invaded by glioma

4

Scheduled intraoperative motor evoked potential monitoring

5

Patients with traumatic brain injury, intracerebral hemorrhage, or cerebral vascular diseases

6

Patients with prolonged emergence, postoperative mechanical ventilation, and/or sedation dependence due to a definite reason (e.g., surgery itself or tumor location)

7

Hypothalamic dysfunction

8

Radiotherapy and/or chemotherapy before surgery

9

Uncontrolled hypertension or severe heart disease that impairs cardiac function (New York Heart Association Functional Classification ≥ III)

10

History of related anesthetic allergy

11

Severe endocrine system dysfunction that impair metabolic index

12

Impaired mental status

13

Drug and/or alcohol abuse

14

Pregnant and/or lactation period patients

15

Neuromuscular diseases

16

Infectious and/or immune diseases with positive biomarker(s)

17

Body mass index > = 35